These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25909201)

  • 21. Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics.
    Rubattu S; Volpe M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natriuretic peptides and heart transplant.
    Almenar L; Martínez-Dolz L; Moro J
    Curr Opin Mol Ther; 2007 Jun; 9(3):282-90. PubMed ID: 17608027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and suppressed B-type natriuretic peptide levels in heart failure.
    Mehra MR; Uber PA; Park MH; Scott RL; Ventura HO; Harris BC; Frohlich ED
    J Am Coll Cardiol; 2004 May; 43(9):1590-5. PubMed ID: 15120816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Emerging Role of Natriuretic Peptides: Igniting the Fat Furnace to Fuel and Warm the Heart.
    Palmer BF; Clegg DJ
    Mayo Clin Proc; 2015 Dec; 90(12):1666-78. PubMed ID: 26518101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardiovascular complications in obesity].
    Dincheva K
    Vutr Boles; 1982; 21(4):7-12. PubMed ID: 6755911
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.
    Poirier P; Giles TD; Bray GA; Hong Y; Stern JS; Pi-Sunyer FX; Eckel RH
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):968-76. PubMed ID: 16627822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence.
    Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM
    Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physiology and clinical role of natriuretic peptides].
    Szabó G; Rigó J; Nagy B
    Orv Hetil; 2011 Jun; 152(26):1025-34. PubMed ID: 21652296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides, gender and cardiovascular risk: what is the link?
    Santhanakrishnan R; Lam CS
    Maturitas; 2012 Feb; 71(2):89-91. PubMed ID: 22192442
    [No Abstract]   [Full Text] [Related]  

  • 31. Nutrition in cardiovascular disease: salt in hypertension and heart failure.
    He FJ; Burnier M; Macgregor GA
    Eur Heart J; 2011 Dec; 32(24):3073-80. PubMed ID: 21705359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurohormonal activation in populations susceptible to heart failure.
    Arnlöv J; Vasan RS
    Heart Fail Clin; 2005 Apr; 1(1):11-23. PubMed ID: 17386830
    [No Abstract]   [Full Text] [Related]  

  • 33. Natriuretic peptides and cerebral hemodynamics.
    Guo S; Barringer F; Zois NE; Goetze JP; Ashina M
    Regul Pept; 2014; 192-193():15-23. PubMed ID: 25107278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natriuretic peptides: anything new in cardiology?].
    Malinowski M; Biernat J; Roleder T; Dalecka AM; Reszka B; Deja MA; Wośf S; Gołba KS
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S578-85. PubMed ID: 20527380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and target organ damage: the heart.
    Schunkert H
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S15-20. PubMed ID: 12457294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac natriuretic peptides: from basic discovery to clinical practice.
    Hayek S; Nemer M
    Cardiovasc Ther; 2011 Dec; 29(6):362-76. PubMed ID: 20433683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential for existing and novel forms of natriuretic peptides.
    Chen HH; Burnett JC
    Heart Fail Clin; 2006 Jul; 2(3):365-73. PubMed ID: 17386905
    [No Abstract]   [Full Text] [Related]  

  • 38. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
    Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D
    Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress.
    Mazza R; Imbrogno S; Tota B
    Regul Pept; 2010 Nov; 165(1):86-94. PubMed ID: 20594992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.